NUVECTIS PHARMA INC.
6.0300
08-October-24 15:59:58
15 minutes delayed
Stocks
-0.0400
-0.66%
Today's range
5.9900 - 6.3178
ISIN
N/A
Source
NASDAQ
-
Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
01 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
17 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Nuvectis Pharma, Inc. Reports Second Quarter 2023 Financial Results and Business Highlights
09 Aug 2023 08:00:58 By Nasdaq GlobeNewswire
-
Nuvectis Pharma Set to Join the Russell 2000® and Russell 3000® Indexes
20 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Nuvectis Pharma Announces FDA Clearance of NXP900 IND
15 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Nuvectis Pharma, Inc. Reports First Quarter 2023 Financial Results and Business Highlights
10 May 2023 08:00:02 By Nasdaq GlobeNewswire
-
Correction: Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
27 Apr 2023 10:14:23 By Nasdaq GlobeNewswire
-
Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
27 Apr 2023 08:00:02 By Nasdaq GlobeNewswire
-
10 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
17 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
Nuvectis Pharma to Participate in a Fireside Chat at the 35th Annual Roth Conference
10 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
Nuvectis Pharma, Inc. Reports Fiscal Year 2022 Financial Results and Business Highlights
07 Mar 2023 08:00:31 By Nasdaq GlobeNewswire
-
23 Feb 2023 08:00:02 By Nasdaq GlobeNewswire
-
01 Dec 2022 08:00:01 By Nasdaq GlobeNewswire
-
Nuvectis Pharma, Inc. Reports Third Quarter 2022 Financial Results and Business Highlights
08 Nov 2022 08:00:40 By Nasdaq GlobeNewswire
-
18 Oct 2022 08:00:50 By Nasdaq GlobeNewswire
-
Nuvectis Pharma, Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference
03 Oct 2022 16:30:00 By Nasdaq GlobeNewswire